Anne Romanic Arnold is a distinguished inventor based in Wynnewood, Pennsylvania. She has made significant contributions to the field of biomedical research, holding a total of five patents. Her work focuses on developing therapeutic methods and diagnostic assays that have the potential to address various human diseases and disorders.

Latest Patents

Among her latest patents is the invention related to the splicing variant of human membrane-type matrix metalloproteinase-5 (MT-MMP5-L). This patent discloses the MT-MMP5-L polypeptides and polynucleotides, along with methods for producing these polypeptides through recombinant techniques. Additionally, it outlines methods for utilizing MT-MMP5-L polypeptides and polynucleotides in therapy and diagnostic assays. Another notable patent involves methods of screening for agonists and antagonists of the interaction between the human KIAA0001 receptor and various ligands. This invention has potential applications in treating a wide range of conditions, including infections, cancers, diabetes, and neurodegenerative diseases.

Career Highlights

Anne has worked with prominent organizations such as SmithKline Beecham Corporation and Sb Laboratoires Pharmaceutiques. Her experience in these companies has allowed her to develop her innovative ideas and contribute to significant advancements in medical research.

Collaborations

Some of her notable coworkers include Usman Shabon and Anthony J. Arleth. Their collaborative efforts have further enhanced the impact of her inventions in the biomedical field.

Conclusion

Anne Romanic Arnold's contributions to innovation in biomedical research are noteworthy. Her patents reflect her commitment to improving human health through scientific advancements. Her work continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com